(Q54569175)

1 June 2018

title

Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome. (English)

1 reference

1 June 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

ORCID Public Data File 2021

author name string

Priscila Daniele Ramos Cirilo

1

1 reference

1 June 2018

Fabíola Encinas Rosa

2

1 reference

1 June 2018

Maria Fernanda Moreira Ferraz

3

1 reference

1 June 2018

Cláudia Aparecida Rainho

4

1 reference

1 June 2018

Anaglória Pontes

5

1 reference

1 June 2018

Silvia Regina Rogatto

6

1 reference

1 June 2018

publication date

9 August 2011

1 reference

1 June 2018

Gynecological Endocrinology

published in

1 reference

1 June 2018

volume

28

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

190-194

1 reference

1 June 2018

Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2011.593661

10.3109/09513590.2011.593661

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21824047

1 reference

1 June 2018